(150 days)
Not Found
No
The document describes a simple ECG cable and explicitly states "Mentions AI, DNN, or ML: Not Found".
No.
The device is used for transmitting signals for diagnostic and monitoring purposes, not for treating a condition.
Yes
The "Intended Use / Indications for Use" section explicitly states that the device is used for "both diagnostic and monitoring purposes."
No
The device description explicitly states it is an "external device" and describes physical components like cables, leadwire clips, and a trunk cable, indicating it is a hardware device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The BSC Removable Patient Leads ECG Cable is used to transmit electrical signals generated by the heart from electrodes placed on the patient's skin to an external monitoring system. It does not analyze samples taken from the body.
- Intended Use: The intended use is for transmitting signals for diagnostic and monitoring purposes, which is a function of the connected equipment, not the cable itself performing an in vitro test.
The device is a medical device used for signal transmission in the context of an electrocardiogram, which is an in vivo (within the living body) diagnostic procedure.
N/A
Intended Use / Indications for Use
The Removable Patient Leads ECG Cable is used to transmit signals from patient-connected electrodes or transducers to electrocardiograph recorders/monitors for both diagnostic and monitoring purposes. ECG cables are supplied non-sterile and are not sterilizable; they are reusable devices and are recommended to be used by trained operators in a medical environment. Use is limited by the indications for use of the connected monitoring or diagnostic equipment.
Product codes
DSA
Device Description
The BSC ECG cable, model 6750 is an external device used to transmit ECG signals from electrodes which are affixed to the patient's body to an external BSC programming system that includes an ECG display monitor. Each leadwire clip is attached to ECG patient electrodes. The other end of the leadwire plugs into one end of the trunk cable. The trunk cable then plugs into the BSC programming system.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Attached to electrodes placed at standard specified locations on chest wall and extremities
Indicated Patient Age Range
Not Found
Intended User / Care Setting
trained operators in a medical environment.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Electromagnetic compatibility, electrical safety, biocompatibility and bench testing were performed to support a determination of substantial equivalence. The results of these tests provide reasonable assurance that the proposed device design meets the performance requirements and performs as intended. No new safety or performance issues were found during device testing,
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.2900 Patient transducer and electrode cable (including connector).
(a)
Identification. A patient transducer and electrode cable (including connector) is an electrical conductor used to transmit signals from, or power or excitation signals to, patient-connected electrodes or transducers.(b)
Classification. Class II (performance standards).
0
·DEC 16 2013
K132253
BOSTON SCIENTIFIC REMOVABLE PATIENT LEADS ECG CABLE
2. 510(K) SUMMARY
2.1. GENERAL INFORMATION
| Device Common/Usual
| Generic Name: | ECG Cable |
|---|---|
| Device Trade Name: | Removable Patient Leads ECG Cable |
| Applicant's Name and | |
| Address: | Boston Scientific Corporation |
| 4100 Hamline Avenue North | |
| St. Paul, Minnesota 55112-5798 | |
| ERN: 2124215 | |
| Product Code/ | |
| Regulation Citation: | DSA, Cardiovascular |
| 21 CFR 870.2900 | |
| Contact Name and | |
| Information: | Melissa Klamerus |
| Regulatory Specialist | |
| Phone: 651.582.6771 | |
| Fax: 651.582.5134 | |
| E-mail: melissa.klamerus@bsci.com | |
| Owner /Operator: | Boston Scientific Corporation |
| One Boston Scientific Place | |
| Natick, MA 01760 | |
| ERN: 9912058 | |
| Manufacturing | |
| Facility: | Technical Services for Electronics Inc. (TSE) |
| 2f No. 21 Jian Kang Road | |
| Chung Ho City Taiwan | |
| ERN: 3008483389 |
2.2. DEVICE
Removable Patient Leads ECG Cable.
2.3. PREDICATE DEVICE
ECG Patient Cables & Lead Wire System, K771645 (Oct 13, 1977).
Property of Boston Scientific Corporation Confidential. Do not Copy July 2013
2-1
1
2.4. DEVICE DESCRIPTION
The BSC ECG cable, model 6750 is an external device used to transmit ECG signals from electrodes which are affixed to the patient's body to an external BSC programming system that includes an ECG display monitor. Each leadwire clip is attached to ECG patient electrodes. The other end of the leadwire plugs into one end of the trunk cable. The trunk cable then plugs into the BSC programming system.
2.5. INDICATIONS FOR USE
The Removable Patient Leads ECG Cable is used to transmit signals from patient-connected electrodes or transducers to electrocardiograph recorders/monitors for both diagnostic and monitoring purposes.
ECG cables are supplied non-sterile and are not sterilizable; they are reusable devices and are recommended to be used by trained operators in a medical environment. Use is limited by the indications for use of the connected monitoring or diagnostic equipment.
2.6. DEVICE COMPARISON TO PREDICATE
The BSC ECG cable incorporates substantially equivalent design, packaging, fundamental technology, and indications for use as the predicate, ECG Patient Cables & Lead Wire System (K771645). See Table 2-1 for a comparison between the BSC ECG cable and the predicate device.
| Characteristic | BSC ECG Cable | Tyco predicate device |
|---|---|---|
| Indications for use | ECG cable is used to transmit | |
| signals from patient-connected | ||
| electrodes or transducers to | ||
| electrocardiograph | ||
| recorders/monitors for both | ||
| diagnostic and monitoring | ||
| purposes. | ECG leadwire is used to transmit | |
| signals from patient-connected | ||
| electrodes or transducers to | ||
| electrocardiograph | ||
| recorders/monitors for both | ||
| diagnostic and monitoring | ||
| purposes. | ||
| Patient usage | Reusable | Reusable |
| Sterility | Supplied non-sterile; cannot be | |
| sterilized | Supplied non-sterile; cannot be | |
| sterilized | ||
| Anatomical sites | Attached to electrodes placed at | |
| standard specified locations on | ||
| chest wall and extremities | Attached to electrodes placed at | |
| standard specified locations on | ||
| chest wall and extremities | ||
| Functionality | transmit signals from 5 patient- | |
| connected leadwires | transmit signals from 5 patient- | |
| connected leadwires |
| Table 2-1: Comparison between BSC ECG cable and predicate device | ||
|---|---|---|
Property of Boston Scientific Corporation Confidential. Do not Copy July 2013
2
K132253 BOSTON SCIENTIFIC REMOVABLE PATIENT LEADS ECG CARLE
TRADITIONAL 510(K)
| Design/
Appearance | Number of leadwires
(patient wire) | 5 | 5 |
|-----------------------|---------------------------------------------------|----------------------------------------------------------|----------------------------------------------------------|
| | Trunk cable length | $120 \pm 6$ inches | $120 \pm 6$ inches |
| | Leadwire length
(each) | $40 \pm 1.5$ inches | $40 \pm 1.5$ inches |
| | Connector - Patient
end | patient clip | patient clip |
| | Connector - Monitor
end | 6 pin DIN AAMI | 6 pin DIN AAMI |
| | Packaging | outer labeled box inner labeled bubble pouch non-sterile | outer labeled box inner labeled bubble pouch non-sterile |
| | Leadwire colors
(ANSI/AAMI/
IEC 60601-2-27) | white green brown red black | white green brown red black |
| | Cable Coating
Materials | Polyvinyl Chloride (PVC) Santoprene Elastollan | Polyvinyl Chloride (PVC) Santoprene |
2.7. PERFORMANCE DATA
Electromagnetic compatibility, electrical safety, biocompatibility and bench testing were performed to support a determination of substantial equivalence. The results of these tests provide reasonable assurance that the proposed device design meets the performance requirements and performs as intended. No new safety or performance issues were found during device testing,
2.8. CONCLUSION .
Based on the indications for use, technological characteristics, and safety and performance testing, the Removable Patient Leads ECG Cable has been shown to be appropriate for its indications for use and is considered to be substantially equivalent to the predicate ECG cable, K771645.
3
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a stylized graphic of an abstract human figure with outstretched arms, accompanied by the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the graphic. The text is in a circular format, with the graphic positioned in the center.
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
December 16, 2013
Boston Scientific Cardiac Rhythm Management Ms. Melissa Klamerus 4100 Hamline Avenue North St. Paul, MN 55112
Re: K132253
Trade/Device Name: Boston Scientific Removable Patient Leads ECG Cable, Model 6750 Regulatory Number: 21 CFR 870.2900 Regulation Name: Patient Transducer and Electrode Cable (including Connector) Regulatory Class: Class II (Two) Product Code: DSA Dated: November 14, 2013 Received: November 15, 2013
Dear Ms. Klamerus:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
4
Page 2 - Ms. Melissa Klamerus
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm 1 15809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers. International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours.
Owen-P. Faris -S
for
Bram D. Zuckerman Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
Boston Scientific Removable Patient Leads ECG Cable Traditional 510(k)
APPENDIX 1
. .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Indications for Use Statement
| 510(k) Number
| (if known) | |
|---|---|
| Device Name | Removable Patient Leads ECG Cable |
| Indications for | |
| Use | The BSC Removable Patient Leads ECG Cable is used to transmit |
| signals from patient-connected electrodes or transducers to | |
| electrocardiograph recorders/monitors for both diagnostic and | |
| monitoring purposes. ECG cables are supplied non-sterile and are | |
| not sterilizable; they are reusable devices and are recommended to | |
| be used by trained operators in a medical environment. Use is | |
| limited by the indications for use of the connected monitoring or | |
| diagnostic equipment. |
Prescription Use _ × (Per 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (Per 21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Clive Z.
Digitally signed by Owen P. Faris -5 Date: 2013. 12.16 16:21:28 -05'00'